Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Pallarés V[au]:

Search results

Items: 1 to 50 of 79

1.

A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models.

Falgàs A, Pallarès V, Unzueta U, Céspedes MV, Arroyo-Solera I, Moreno MJ, Gallardo A, Mangues MA, Sierra J, Villaverde A, Vázquez E, Mangues R, Casanova I.

Haematologica. 2019 Jun 27. pii: haematol.2018.211490. doi: 10.3324/haematol.2018.211490. [Epub ahead of print]

2.

[SEA/SEMERGEN consensus document 2019: Dietary recommendations in the prevention of cardiovascular disease].

Pascual V, Perez Martinez P, Fernández JM, Solá R, Pallarés V, Romero Secín A, Pérez Jiménez F, Ros E.

Semergen. 2019 Jul - Aug;45(5):333-348. doi: 10.1016/j.semerg.2019.02.015. Epub 2019 Jun 1. Spanish.

PMID:
31164311
3.

Vitamin B3 impairs reverse cholesterol transport in Apolipoprotein E-deficient mice.

Méndez-Lara KA, Santos D, Farré N, Nan MN, Pallarès V, Pérez-Pérez A, Alonso N, Escolà-Gil JC, Blanco-Vaca F, Julve J.

Clin Investig Arterioscler. 2019 May 13. pii: S0214-9168(19)30047-6. doi: 10.1016/j.arteri.2019.04.001. [Epub ahead of print] English, Spanish.

PMID:
31097214
4.

SEA/SEMERGEN consensus document 2019: Dietary recommendations in the prevention of cardiovascular disease.

Pascual V, Perez Martinez P, Fernández JM, Solá R, Pallarés V, Romero Secín A, Pérez Jiménez F, Ros E.

Clin Investig Arterioscler. 2019 Jul - Aug;31(4):186-201. doi: 10.1016/j.arteri.2019.02.004. Epub 2019 Mar 23. English, Spanish.

PMID:
30910237
5.

Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.

Arroyo-Solera I, Pavón MÁ, León X, López M, Gallardo A, Céspedes MV, Casanova I, Pallarès V, López-Pousa A, Mangues MA, Barnadas A, Quer M, Mangues R.

Head Neck. 2019 Feb;41(2):429-439. doi: 10.1002/hed.25437. Epub 2018 Dec 12.

PMID:
30548470
6.

Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia.

Pallarès V, Hoyos M, Chillón MC, Barragán E, Prieto Conde MI, Llop M, Falgàs A, Céspedes MV, Montesinos P, Nomdedeu JF, Brunet S, Sanz MÁ, González-Díaz M, Sierra J, Mangues R, Casanova I.

Cancers (Basel). 2018 Nov 13;10(11). pii: E436. doi: 10.3390/cancers10110436.

7.

Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study.

Navarro-Pérez J, Orozco-Beltran D, Gil-Guillen V, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Martin-Moreno JM, Redon J, Tellez-Plaza M; ESCARVAL STUDY GROUP.

BMC Cardiovasc Disord. 2018 Sep 4;18(1):180. doi: 10.1186/s12872-018-0914-1.

8.

CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis.

Moreno MJ, Gallardo A, Novelli S, Mozos A, Aragó M, Pavón MÁ, Céspedes MV, Pallarès V, Falgàs A, Alcoceba M, Blanco O, Gonzalez-Díaz M, Sierra J, Mangues R, Casanova I.

PLoS One. 2018 Jun 19;13(6):e0198789. doi: 10.1371/journal.pone.0198789. eCollection 2018.

9.

Selective CXCR4+ Cancer Cell Targeting and Potent Antineoplastic Effect by a Nanostructured Version of Recombinant Ricin.

Díaz R, Pallarès V, Cano-Garrido O, Serna N, Sánchez-García L, Falgàs A, Pesarrodona M, Unzueta U, Sánchez-Chardi A, Sánchez JM, Casanova I, Vázquez E, Mangues R, Villaverde A.

Small. 2018 Jun;14(26):e1800665. doi: 10.1002/smll.201800665. Epub 2018 May 29.

PMID:
29845742
10.

Extracting orthogonal subject- and condition-specific signatures from fMRI data using whole-brain effective connectivity.

Pallarés V, Insabato A, Sanjuán A, Kühn S, Mantini D, Deco G, Gilson M.

Neuroimage. 2018 Sep;178:238-254. doi: 10.1016/j.neuroimage.2018.04.070. Epub 2018 May 22.

11.

[Management of heart failure in cardiology and primary care (MICCAP) program: Improving the management of patients with heart failure].

Barrios V, Escobar C, Pallares V, Egocheaga MI, Lobos JM, Bover R, Gómez Doblas JJ, Cosín J.

Semergen. 2018 Nov - Dec;44(8):572-578. doi: 10.1016/j.semerg.2018.02.006. Epub 2018 Mar 26. Spanish.

PMID:
29599063
12.

Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.

Cedó L, Santos D, Roglans N, Julve J, Pallarès V, Rivas-Urbina A, Llorente-Cortes V, Laguna JC, Blanco-Vaca F, Escolà-Gil JC.

PLoS One. 2017 Dec 15;12(12):e0189834. doi: 10.1371/journal.pone.0189834. eCollection 2017.

13.

[Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology].

Cases A, Egocheaga MI, Tranche S, Pallarés V, Ojeda R, Górriz JL, Portolés JM.

Semergen. 2018 Jan - Feb;44(1):37-41. doi: 10.1016/j.semerg.2017.10.006. Epub 2017 Dec 9. Spanish.

PMID:
29229312
14.

[Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology].

Cases A, Egocheaga MI, Tranche S, Pallarés V, Ojeda R, Górriz JL, Portolés JM.

Aten Primaria. 2018 Jan;50(1):60-64. doi: 10.1016/j.aprim.2017.09.007. Epub 2017 Dec 7. Spanish.

15.

Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology.

Cases A, Egocheaga MI, Tranche S, Pallarés V, Ojeda R, Górriz JL, Portolés JM.

Nefrologia. 2018 Jan - Feb;38(1):8-12. doi: 10.1016/j.nefro.2017.09.004. Epub 2017 Nov 9. English, Spanish.

16.

NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients.

Pallarès V, Hoyos M, Chillón MC, Barragán E, Conde MIP, Llop M, Céspedes MV, Nomdedeu JF, Brunet S, Sanz MÁ, González-Díaz M, Sierra J, Casanova I, Mangues R.

Oncotarget. 2017 Jun 16;8(44):76003-76014. doi: 10.18632/oncotarget.18537. eCollection 2017 Sep 29.

17.

Inflammatory status and uricaemia determine HDL-cholesterol levels in hypertensive adults over 65: an analysis of the FAPRES register.

Quintanilla MA, Andrés M, Pascual E, Pallarés V, Fácila L, Morillas P; FAPRES Research Group.

Rheumatol Int. 2017 Jun;37(6):941-948. doi: 10.1007/s00296-017-3683-8. Epub 2017 Mar 14.

PMID:
28293775
18.

Consensus document for the use of the Polypill in the secondary prevention of cardiovascular disease.

González-Juanatey JR, Mostaza JM, Lobos JM, Abarca B, Llisterri JL, Baron-Esquivias G, Galve E, Lidón RM, Garcia-Moll FX, Sánchez PL, Suárez C, Millán J, Pallares V, Alemán JJ, Egocheaga I.

Med Clin (Barc). 2017 Feb 9;148(3):139.e1-139.e15. doi: 10.1016/j.medcli.2016.10.031. Epub 2016 Dec 16. English, Spanish.

PMID:
27993410
19.

Renal function and attributable risk of death and cardiovascular hospitalization in patients with cardiovascular risk factors from a registry-based cohort: the Estudio Cardiovascular Valencia-risk study.

Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita-Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Martin-Moreno JM, Redon J; ESCARVAL STUDY GROUP.

J Hypertens. 2016 Nov;34(11):2266-73. doi: 10.1097/HJH.0000000000001089.

PMID:
27584973
20.

Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study.

Arroyo D, Betriu A, Valls J, Gorriz JL, Pallares V, Abajo M, Gracia M, Valdivielso JM, Fernandez E; Investigators from the NEFRONA study.

Nephrol Dial Transplant. 2017 Mar 1;32(3):513-520. doi: 10.1093/ndt/gfw039.

PMID:
27190385
21.

[Use of the CHADS2 score as a predictor of the risk of mortality in hypertensive patients. The FAPRES study].

Castilla E, Morillas P, Gómez M, Ahumada M, Monteagudo M, Fácila L, Pallares V.

Med Clin (Barc). 2016 Jun 3;146(11):478-83. doi: 10.1016/j.medcli.2016.03.015. Epub 2016 Apr 30. Spanish.

PMID:
27143530
22.

Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study.

Redon J, Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Sanz G, Martin-Moreno JM; ESCARVAL Study Group.

J Hypertens. 2016 Jun;34(6):1075-83. doi: 10.1097/HJH.0000000000000930.

PMID:
27074896
23.

Brain size regulations by cbp haploinsufficiency evaluated by in-vivo MRI based volumetry.

Ateca-Cabarga JC, Cosa A, Pallarés V, López-Atalaya JP, Barco Á, Canals S, Moratal D.

Sci Rep. 2015 Nov 6;5:16256. doi: 10.1038/srep16256.

24.

Neurosurgery planning in rodents using a magnetic resonance imaging assisted framework to target experimentally defined networks.

Pallarés V, Moya J, Samper-Belda FJ, Canals S, Moratal D.

Comput Methods Programs Biomed. 2015 Sep;121(2):66-76. doi: 10.1016/j.cmpb.2015.05.011. Epub 2015 Jun 6.

PMID:
26094858
25.

Evolution of clinical profile, treatment and blood pressure control in treated hypertensive patients according to the sex from 2002 to 2010 in Spain.

Barrios V, Escobar C, Alonso-Moreno FJ, Prieto MA, Pallares V, Rodríguez-Roca G, Llisterri JL; Working Group of Arterial Hypertension of the Spanish Society of Primary Care Physicians (Group HTASEMERGEN), the PRESCAP 2010 investigators.

J Hypertens. 2015 May;33(5):1098-107. doi: 10.1097/HJH.0000000000000502.

PMID:
25909703
26.

The CHADS2 Score to Predict Stroke Risk in the Absence of Atrial Fibrillation in Hypertensive Patients Aged 65 Years or Older.

Morillas P, Pallarés V, Fácila L, Llisterri JL, Sebastián ME, Gómez M, Castilla E, Camarasa R, Sandin M, García-Honrubia A; FAPRES registry investigators.

Rev Esp Cardiol (Engl Ed). 2015 Jun;68(6):485-91. doi: 10.1016/j.rec.2014.06.027. Epub 2014 Dec 2.

PMID:
25487320
27.

Clinical profile and blood pressure control in patients managed in primary care in Spain: are there any differences between the young and the old?

Barrios V, Escobar C, Calderón A, Moreno FJ, Pallarés V, Galgo A; Working Group of Arterial Hypertension of the Spanish Society of Primary Care Physicians (HTA/SEMERGEN Group) and the researchers of the PRESCAP 2010 Study.

Rev Esp Cardiol (Engl Ed). 2013 Oct;66(10):824-5. doi: 10.1016/j.rec.2013.04.014. Epub 2013 Jul 10. No abstract available.

PMID:
24773867
28.

Gallic acid is an active component for the anticarcinogenic action of grape seed procyanidins in pancreatic cancer cells.

Cedó L, Castell-Auví A, Pallarès V, Macià A, Blay M, Ardévol A, Motilva MJ, Pinent M.

Nutr Cancer. 2014;66(1):88-96. doi: 10.1080/01635581.2014.851714. Epub 2013 Dec 10.

PMID:
24325191
29.

Functional MRI of long-term potentiation: imaging network plasticity.

Alvarez-Salvado E, Pallarés V, Moreno A, Canals S.

Philos Trans R Soc Lond B Biol Sci. 2013 Dec 2;369(1633):20130152. doi: 10.1098/rstb.2013.0152. Print 2014 Jan 5.

30.

Gender differences related to the presence of atrial fibrillation in older hypertensive patients.

Fácila L, Pallarés V, Morillas P, Cordero A, Llisterri JL, Sánchis C, Gorriz JL, Castillo J, Gil V, Redon J.

World J Cardiol. 2013 May 26;5(5):124-31. doi: 10.4330/wjc.v5.i5.124.

31.

Clinical inertia in poorly controlled elderly hypertensive patients: a cross-sectional study in Spanish physicians to ascertain reasons for not intensifying treatment.

Gil-Guillén V, Orozco-Beltrán D, Carratalá-Munuera C, Márquez-Contreras E, Durazo-Arvizu R, Cooper R, Pertusa-Martínez S, Pita-Fernandez S, González-Segura D, Martin-de-Pablo JL, Pallarés V, Fernández A, Redón J.

Am J Cardiovasc Drugs. 2013 Jun;13(3):213-9. doi: 10.1007/s40256-013-0025-4.

PMID:
23585143
32.

Grape seed procyanidin extract reduces the endotoxic effects induced by lipopolysaccharide in rats.

Pallarès V, Fernández-Iglesias A, Cedó L, Castell-Auví A, Pinent M, Ardévol A, Salvadó MJ, Garcia-Vallvé S, Blay M.

Free Radic Biol Med. 2013 Jul;60:107-14. doi: 10.1016/j.freeradbiomed.2013.02.007. Epub 2013 Feb 21.

PMID:
23439188
33.

Grape Seed Procyanidin Extract Improves Insulin Production but Enhances Bax Protein Expression in Cafeteria-Treated Male Rats.

Cedó L, Castell-Auví A, Pallarès V, Blay M, Ardévol A, Pinent M.

Int J Food Sci. 2013;2013:875314. doi: 10.1155/2013/875314. Epub 2013 Apr 18.

34.

Grape seed procyanidin extract modulates proliferation and apoptosis of pancreatic beta-cells.

Cedó L, Castell-Auví A, Pallarès V, Blay M, Ardévol A, Arola L, Pinent M.

Food Chem. 2013 May 1;138(1):524-30. doi: 10.1016/j.foodchem.2012.10.088. Epub 2012 Nov 12.

PMID:
23265520
35.

Procyanidins modulate microRNA expression in pancreatic islets.

Castell-Auví A, Cedó L, Movassat J, Portha B, Sánchez-Cabo F, Pallarès V, Blay M, Pinent M, Ardévol A.

J Agric Food Chem. 2013 Jan 16;61(2):355-63. doi: 10.1021/jf303972f. Epub 2013 Jan 4.

PMID:
23215023
36.

Grape seed procyanidins improve β-cell functionality under lipotoxic conditions due to their lipid-lowering effect.

Castell-Auví A, Cedó L, Pallarès V, Blay M, Pinent M, Ardévol A.

J Nutr Biochem. 2013 Jun;24(6):948-53. doi: 10.1016/j.jnutbio.2012.06.015. Epub 2012 Sep 17.

PMID:
22995387
37.

Treatment and blood pressure control in Spain during 2002-2010.

Llisterri JL, Rodriguez-Roca GC, Escobar C, Alonso-Moreno FJ, Prieto MA, Barrios V, González-Alsina D, Divisón JA, Pallarés V, Beato P; Working Group of Arterial Hypertension of the Spanish Society of Primary Care Physicians Group HTASEMERGEN; PRESCAP 2010 investigators.

J Hypertens. 2012 Dec;30(12):2425-31. doi: 10.1097/HJH.0b013e3283592583.

PMID:
22990354
38.

Pancreatic islet proteome profile in Zucker fatty rats chronically treated with a grape seed procyanidin extract.

Cedó L, Castell-Auví A, Pallarès V, Ubaida Mohien C, Baiges I, Blay M, Ardévol A, Pinent M.

Food Chem. 2012 Dec 1;135(3):1948-56. doi: 10.1016/j.foodchem.2012.06.042. Epub 2012 Jun 29.

PMID:
22953944
39.

Procyanidins modify insulinemia by affecting insulin production and degradation.

Castell-Auví A, Cedó L, Pallarès V, Blay MT, Pinent M, Motilva MJ, Garcia-Vallvé S, Pujadas G, Maechler P, Ardévol A.

J Nutr Biochem. 2012 Dec;23(12):1565-72. doi: 10.1016/j.jnutbio.2011.10.010. Epub 2012 Mar 22.

PMID:
22444499
40.

Enhanced anti-inflammatory effect of resveratrol and EPA in treated endotoxin-activated RAW 264.7 macrophages.

Pallarès V, Calay D, Cedó L, Castell-Auví A, Raes M, Pinent M, Ardévol A, Arola L, Blay M.

Br J Nutr. 2012 Nov 14;108(9):1562-73. doi: 10.1017/S0007114511007057. Epub 2012 Jan 6.

PMID:
22221545
41.

Additive, antagonistic, and synergistic effects of procyanidins and polyunsaturated fatty acids over inflammation in RAW 264.7 macrophages activated by lipopolysaccharide.

Pallarès V, Calay D, Cedó L, Castell-Auví A, Raes M, Pinent M, Ardévol A, Arola L, Blay M.

Nutrition. 2012 Apr;28(4):447-57. doi: 10.1016/j.nut.2011.07.027. Epub 2011 Dec 14.

PMID:
22169119
42.

The effects of a cafeteria diet on insulin production and clearance in rats.

Castell-Auví A, Cedó L, Pallarès V, Blay M, Ardévol A, Pinent M.

Br J Nutr. 2012 Oct;108(7):1155-62. Epub 2011 Dec 12.

PMID:
22152054
43.

Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study.

Gil-Guillén V, Orozco-Beltrán D, Márquez-Contreras E, Durazo-Arvizu R, Cooper R, Pita-Fernández S, González-Segura D, Carratalá-Munuera C, Martín de Pablo JL, Pallarés V, Pertusa-Martínez S, Fernández A, Redón J.

Drugs Aging. 2011 Dec 1;28(12):981-92. doi: 10.2165/11596640-000000000-00000.

PMID:
22117096
44.

[In the identification of cardiovascular risk with the SCORE model, could we recommend its calculation interchangeably with total cholesterol or atherogenic index? Concordance between total cholesterol and atherogenic index in the SCORE table].

Gil-Guillén VF, Orozco-Beltrán D, Pita-Fernández S, Carratalá-Munuera C, Redón J, Navarro J, Pallarés V, Pertusa S.

Rev Esp Cardiol. 2011 May;64(5):421-3. doi: 10.1016/j.recesp.2010.06.001. Epub 2011 Mar 11. Spanish.

45.

[Differences in the degree of control of arterial hypertension according to the measurement procedure of blood pressure in patients ≥ 65 years. FAPRES study].

Llisterri JL, Morillas P, Pallarés V, Fácila L, Sanchís C, Sánchez T; FAPRES researchers.

Rev Clin Esp. 2011 Feb;211(2):76-84. doi: 10.1016/j.rce.2010.11.005. Epub 2011 Feb 19. Spanish.

PMID:
21338985
46.

Rationale and methods of the cardiometabolic Valencian study (Escarval-Risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia.

Gil-Guillen V, Orozco-Beltran D, Redon J, Pita-Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fluixa C, Fernandez A, Martin-Moreno JM, Pascual-de-la-Torre M, Trillo JL, Durazo-Arvizu R, Cooper R, Hermenegildo M, Rosado L.

BMC Public Health. 2010 Nov 22;10:717. doi: 10.1186/1471-2458-10-717.

47.

Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients aged >or=65 years. The FAPRES trial.

Morillas P, Pallarés V, Llisterri JL, Sanchis C, Sánchez T, Fácila L, Pérez-Alonso M, Castillo J, Redón J, Bertomeu V; FAPRES RegistryResearchers.

Rev Esp Cardiol. 2010 Aug;63(8):943-50. English, Spanish.

48.

Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES.

Morillas P, Pallarés V, Llisterri JL, Sanchis C, Sánchez T, Fácila L, Pérez-Alonso M, Castillo J, Redón J, Bertomeu V; en representación de los investigadores del registro FAPRES.

Rev Esp Cardiol. 2010 Aug;63(8):943-50. doi: 10.1016/S0300-8932(10)70206-2. Epub 2010 Sep 16. English, Spanish.

49.

Modulatory effect of grape-seed procyanidins on local and systemic inflammation in diet-induced obesity rats.

Terra X, Pallarés V, Ardèvol A, Bladé C, Fernández-Larrea J, Pujadas G, Salvadó J, Arola L, Blay M.

J Nutr Biochem. 2011 Apr;22(4):380-7. doi: 10.1016/j.jnutbio.2010.03.006. Epub 2010 Jul 23.

PMID:
20655715
50.

Development of a coculture system to evaluate the bioactivity of plant extracts on pancreatic β-cells.

Castell-Auví A, Cedó L, Pallarés V, Blay MT, Pinent M, Motilva MJ, Arola L, Ardévol A.

Planta Med. 2010 Oct;76(14):1576-81. doi: 10.1055/s-0029-1241002. Epub 2010 Mar 22.

PMID:
20309797

Supplemental Content

Loading ...
Support Center